1.Clinical features and treatment of invasive fungal infection in 47 patients with hematological malignancies.
Yan ZHU ; Shu-ping CHEN ; Yi-gang SHU ; Ya-jing XU
Journal of Central South University(Medical Sciences) 2008;33(1):89-92
OBJECTIVE:
To analyze the clinical features of invasive fungal infection in patients with hematological malignancies and to compare the the therapeutic effect of fluconazole and intraconazole.
METHODS:
The clinical manifestations, mycological features, and the therapeutic results of 47 patients were retrospectively analyzed. Fluconazole was given to 17 paitents, intraconazole was given to 21 patients, and intraconazole to the other 9 patients after they had no effect with fluconazole.
RESULTS:
All patients had fever. The lung and the mouth cavity were the main locations of infection (53.2% and 21.3%, respectively). Fungi were found in 23 (48.9%) patients, in which the majority were Candida albicans and Aspergillus (56.5% and 26.1%, respectively). Intraconazole was more effective than fluconazole (63.3% vs. 34.6%, P<0.05) with no serious side effect.
CONCLUSION
The most common clinical features of IFI are fever, lung infection, and oral infection in patients with hematological malignancies. Candida albicans and Aspergillus infection are common. Intraconazole is safe and effective for invasive fungal infection.
Adolescent
;
Adult
;
Aged
;
Antifungal Agents
;
therapeutic use
;
Aspergillosis
;
complications
;
diagnosis
;
drug therapy
;
Candidiasis
;
complications
;
diagnosis
;
drug therapy
;
Female
;
Fluconazole
;
therapeutic use
;
Hematologic Neoplasms
;
microbiology
;
Humans
;
Itraconazole
;
therapeutic use
;
Lung Diseases, Fungal
;
complications
;
diagnosis
;
drug therapy
;
Male
;
Middle Aged
2.Clinical analysis of 81 cases of pulmonary cryptococcosis.
Dong XIE ; Xiao-feng CHEN ; Ge-ning JIANG ; Zhi-fei XU ; Xiao-fang YOU ; Chang CHEN ; Xiao ZHOU ; Jia-an DING
Chinese Journal of Surgery 2012;50(5):430-433
OBJECTIVETo clarify the clinical feature, diagnosis and therapy of the pulmonary cryptococcosis (PC).
METHODSA retrospective study of cases with PC who were diagnosed by pathological examinations between January 1996 and December 2010 was conducted. Eighty-one cases were enrolled in the study (58 male and 23 female patients; mean age of (51±11) years). Forty-one cases were asymptomatic at the time of diagnosis. There were single pulmonary lesions in 50 cases, and multiple lesions in 31 cases. Fourteen lesions (17.3%) were located in left upper lobe, 27 (33.3%) in left lower lobe, 21 (25.9%) in right upper lobe, 3 (3.7%) in right middle lobe, 28 (34.6%) in right lower lobe, and 3 (3.7%) diffusely involved bilateral lungs. The tumors ranged from 0.8 to 10.0 cm in diameter with a mean of (2.9±1.8) cm. All the cases were misdiagnosis prior to the surgical resection, and histologically confirmed by postoperative pathological specimens.
RESULTSAll the cases received surgical treatment including complete resection in 69 cases, and palliative resection in 12 cases. Resections were performed by means of video-assisted thoracoscopy in 31 cases and thoracotomy in 50 cases. Surgical resections included pulmonary wedge excisions in 42 cases, and lobectomies in 39 cases. After histological confirmation, 63 cases (77.8%) were treated with antifungal agents, which consisted of fluconazole in 38 cases, itraconazole in 18 cases, amphotericin B in 6 cases, and flucytosine in 4 cases. There were no intraoperative death, but two cases died for cryptococcal meningoencephalitis in the postoperative period. Operative morbidity occurred in 7 (8.6%) cases. The median follow-up was 42.5 months (6 to 84 months). There were 2 local relapses of PC, and 9 cases with complications of anti-fungal agents.
CONCLUSIONSThe clinical manifestations of PC are mild and non-specific, with no characteristic radiographic manifestations. Surgical resection is usually indicated for definite diagnosis and treatment. Antifungal drug therapy is indispensable even after complete resection.
Adult ; Aged ; Antifungal Agents ; therapeutic use ; Cryptococcosis ; diagnosis ; drug therapy ; surgery ; Female ; Follow-Up Studies ; Humans ; Lung ; microbiology ; pathology ; Lung Diseases, Fungal ; diagnosis ; drug therapy ; surgery ; Male ; Middle Aged ; Retrospective Studies ; Young Adult
3.Chronic Cavitary Pulmonary Histoplasmosis in a Non-HIV and Immunocompromised Patient without Overseas Travel History.
Eun Ju JUNG ; Dae Won PARK ; Jung Woo CHOI ; Won Suk CHOI
Yonsei Medical Journal 2015;56(3):871-874
Korea is not known as an endemic area for Histoplasma. However, we experienced a case of histoplasmosis in a person who had never been abroad. A 65-year-old female was admitted to the hospital for evaluation of multiple lung nodules. A computed tomography (CT) scan of the chest showed multiple ill-defined consolidations and cavitations in all lobes of both lungs. The patient underwent a CT-guided lung biopsy, and a histopathology study showed findings compatible with histoplasmosis. Based on biopsy results and clinical findings, the patient was diagnosed with chronic cavitary pulmonary histoplasmosis. The patient recovered completely following itraconazole treatment. This is the first case report of pulmonary histoplasmosis unconnected with either HIV infection or endemicity in Korea.
Aged
;
Antifungal Agents/therapeutic use
;
Biopsy
;
Female
;
Histoplasma/*isolation & purification
;
Histoplasmosis/*diagnosis/drug therapy/microbiology
;
Humans
;
*Immunocompromised Host
;
Itraconazole/therapeutic use
;
Lung Diseases, Fungal/*diagnosis/drug therapy
;
Republic of Korea
;
Tomography, X-Ray Computed
;
Treatment Outcome
4.Chronic Cavitary Pulmonary Histoplasmosis in a Non-HIV and Immunocompromised Patient without Overseas Travel History.
Eun Ju JUNG ; Dae Won PARK ; Jung Woo CHOI ; Won Suk CHOI
Yonsei Medical Journal 2015;56(3):871-874
Korea is not known as an endemic area for Histoplasma. However, we experienced a case of histoplasmosis in a person who had never been abroad. A 65-year-old female was admitted to the hospital for evaluation of multiple lung nodules. A computed tomography (CT) scan of the chest showed multiple ill-defined consolidations and cavitations in all lobes of both lungs. The patient underwent a CT-guided lung biopsy, and a histopathology study showed findings compatible with histoplasmosis. Based on biopsy results and clinical findings, the patient was diagnosed with chronic cavitary pulmonary histoplasmosis. The patient recovered completely following itraconazole treatment. This is the first case report of pulmonary histoplasmosis unconnected with either HIV infection or endemicity in Korea.
Aged
;
Antifungal Agents/therapeutic use
;
Biopsy
;
Female
;
Histoplasma/*isolation & purification
;
Histoplasmosis/*diagnosis/drug therapy/microbiology
;
Humans
;
*Immunocompromised Host
;
Itraconazole/therapeutic use
;
Lung Diseases, Fungal/*diagnosis/drug therapy
;
Republic of Korea
;
Tomography, X-Ray Computed
;
Treatment Outcome
5.First Report of Cryptococcus Albidus-Induced Disseminated Cryptococcosis in a Renal Transplant Recipient.
Yeon Ah LEE ; Hee Jin KIM ; Tae Won LEE ; Myung Jae KIM ; Mu Hyoung LEE ; Ju Hie LEE ; Chun Gyoo IHM
The Korean Journal of Internal Medicine 2004;19(1):53-57
Cryptococcus albidus, a non-neoformans species of the genus Cryptococcus, is generally regarded as a rare cause of disease. There have been only 14 previously reported cases in which this organism has been isolated as a pathogen, none of which occurred in a renal transplant recipient. A 23-year-old renal transplant recipient taking medication consisting of cyclosporine and prednisolone was admitted with a 10-day history of dry cough, fever and progressive dyspnea. The next day, his respiratory status deteriorated dramatically, and he developed acute respiratory distress syndrome (ARDS) and fulminant septic shock. On the eighth hospital day, tender macules on both his shins coalesced to form erythematous patches. Cryptococcus albidus was isolated by skin biopsy and tissue culture. We report here the first case of disseminated cryptococcosis caused by C. albidus in a renal transplant recipient who had been successfully treated with fluconazole monotherapy.
Adult
;
Antifungal Agents/*therapeutic use
;
Cryptococcosis/diagnosis/drug therapy/*microbiology
;
Cyclosporine/adverse effects
;
Diagnosis, Differential
;
Fluconazole/*therapeutic use
;
Graft Rejection/prevention & control
;
Human
;
Immunocompromised Host
;
Immunosuppressive Agents/adverse effects
;
*Kidney Transplantation
;
Lung Diseases, Fungal/diagnosis/drug therapy/*microbiology
;
Male
;
Opportunistic Infections/diagnosis/*microbiology
;
Tomography, X-Ray Computed
6.Ph+ acute lymphoblastic leukemia combined with lung and brain invasive aspergillosis.
Mei HUANG ; Jian-Feng ZHOU ; Dan RAN ; Yi-Cheng ZHANG ; Han-Ying SUN ; Wen-Li LIU
Journal of Experimental Hematology 2006;14(3):610-613
This study was aimed to investigate the clinical features and therapy of Ph(+) acute lymphoblastic leukemia (Ph(+)ALL) combined with invasive aspergillosis. A series of examination, including routine blood and bone marrow picture analysis, chest roentgenography, cranial computerized tomography and detection of cell genetics etc were carried out for a Ph(+)ALL patient combined with invasive aspergillosis. This patient received chemotherapy with DVCP, idarubicin and imatinib mesylate and was treated with sporanox and amphotericin B (Amb; including Amb-L) and cerebrotomy for drainage because the invasive aspergillosis occurred during myelosuppression. The results showed that patient gained complete remission and the invasive aspergillosis was controlled successfully. It is concluded that patient with Ph(+)ALL has poor prognosis despite intensive conventional chemotherapy, imatinib mesylate may prove to be an effective treatment for Ph(+)ALL. Because detection rate of the fungus is very low, itraconazole in combination with surgical excision of focus is the best treatment of lung and brain invasive aspergillosis.
Antifungal Agents
;
therapeutic use
;
Antineoplastic Combined Chemotherapy Protocols
;
therapeutic use
;
Aspergillosis
;
diagnosis
;
drug therapy
;
Benzamides
;
Brain Diseases
;
complications
;
microbiology
;
Humans
;
Imatinib Mesylate
;
Itraconazole
;
therapeutic use
;
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
;
complications
;
Lung Diseases, Fungal
;
drug therapy
;
etiology
;
Piperazines
;
administration & dosage
;
Precursor Cell Lymphoblastic Leukemia-Lymphoma
;
complications
;
genetics
;
microbiology
;
Pyrimidines
;
administration & dosage
7.Clinical comparative analysis for pulmonary histoplasmosis and progressive disseminated histoplasmosis.
Yan ZHANG ; Xiaoli SU ; Yuanyuan LI ; Ruoxi HE ; Chengping HU ; Pinhua PAN
Journal of Central South University(Medical Sciences) 2016;41(12):1345-1351
To compare clinical features, diagnosis and therapeutic effect between pulmonary histoplasmosis and progressive disseminated histoplasmosis.
Methods: A retrospective analysis for 12 cases of hospitalized patients with histoplasmosis, who was admitted in Xiangya Hospital, Central South University during the time from February 2009 to October 2015, was carried out. Four cases of pulmonary histoplasmosis and 8 cases of progressive disseminated histoplasmosis were included. The differences of clinical features, imaging tests, means for diagnosis and prognosis were analyzed between the two types of histoplasmosis.
Results: The clinical manifestations of pulmonary histoplasmosis were mild, such as dry cough. However, the main clinical symptoms of progressive disseminated histoplasmosis were severe, including recurrence of high fever, superficial lymph node enlargement over the whole body, hepatosplenomegaly, accompanied by cough, abdominal pain, joint pain, skin changes, etc.Laboratory examination showed pancytopenia, abnormal liver function and abnormal coagulation function. One pulmonary case received the operation of left lower lung lobectomy, 3 cases of pulmonary histoplasmosis and 6 cases of progressive disseminated histoplasmosis patients were given deoxycholate amphotericin B, itraconazole, voriconazole or fluconazole for antifungal therapy. One disseminated case discharged from the hospital without treatment after diagnosis of histoplasmosis, and 1 disseminated case combined with severe pneumonia and active tuberculosis died ultimately.
Conclusion: As a rare fungal infection, histoplasmosis is easily to be misdiagnosed. The diagnostic criteria depends on etiology through bone marrow smear and tissues biopsy. Liposomeal amphotericin B, deoxycholate amphotericin B and itraconazole are recommended to treat infection for histoplasma capsulatum.
Abdominal Pain
;
etiology
;
Amphotericin B
;
therapeutic use
;
Antifungal Agents
;
therapeutic use
;
Biopsy
;
Cough
;
epidemiology
;
Death
;
Deoxycholic Acid
;
therapeutic use
;
Diagnostic Errors
;
Drug Combinations
;
Fever
;
etiology
;
Hepatomegaly
;
etiology
;
Histoplasma
;
Histoplasmosis
;
complications
;
diagnosis
;
mortality
;
therapy
;
Humans
;
Invasive Fungal Infections
;
complications
;
diagnosis
;
therapy
;
Itraconazole
;
therapeutic use
;
Lung
;
microbiology
;
surgery
;
Lung Diseases, Fungal
;
diagnosis
;
surgery
;
therapy
;
Pneumonia
;
complications
;
mortality
;
Recurrence
;
Retrospective Studies
;
Splenomegaly
;
etiology
;
Treatment Outcome
;
Tuberculosis
;
complications
;
mortality